Abstract
A number of clinical syndromes have been described that have as their basic foundation a defect in some transport function of the renal tubule (Table 1), and several of them are inherited. Using this model, one is able to define conditions in which single or multiple substances are lost, in which ions or organic solutes are lost, and in which the whole-body pools of these substances are altered due to excessive urinary excretion. The basic pathophysiologic mechanisms underlying these transport defects are described in detail elsewhere (1–4). The purpose of this chapter is to describe current therapy of these conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Scriver CR, Chesney RW, McInnes RR: Genetic aspects of renal tubular transport. Diversity and topology of carriers. Kidney Int 9: 149–171, 1976.
Schneider JA: Hereditary disorders of tubular function. In: BM Tune, SA Mendoza, eds, Pediatric Nephrology. Contemporary Issues in Nephrology, 12th ed. Churchill-Livingston, New York, pp 85–109, 1984.
Chesney RW: Defects of renal tubular transport. In: SG Massry, R Glassock, eds, Textbook of Nephrology. Elsevier, North Holland, pp 3.178–3. 190, 1983.
Chesney RW, Friedman AL: Isolated renal tubular disorders. In: RW Schrier, CW Gottschalk, eds, Diseases of the Kidney, 4th ed. pp 663–688, 1988.
Scriver CR: Familial iminoglycinuria. In: JB Stanbury, JB Wyngaarden, DS Frederickson, JL Goldstein, MS Brown, eds, The Metabolic Basis of Inherited Disease, 5th ed. McGraw-Hill, New York, pp 1792–1803, 1983.
Melana SB, Dallaire L, Lemieux B, Robitaille P, Porter M: Dicarboxylic aminoaciduria: an inborn error of amino acid conservation. J Pediatr 94: 422–427, 1977.
Foreman JW, Segal S: Aminoacidurias. In: HC Gorick, VM Buckalew Jr, eds, Renal Tubular Disorders. Pathophysiology, Diagnosis and Management. Marcel Dekker, New York, pp 131–157, 1985.
Segal S, Thier SO: Cystinuria. In: JB Stanbury, JB Wyngaarden, DS Frederickson, JL Goldstein, MS Brown, eds, The Metabolic Basis of Inherited Disease, 5th ed. McGraw-Hill, New York, pp 1174–1791, 1983.
Pak CYC, Fuller CJ: Assessment of cystine solubility in urine and of heterogeneous nucleation. J Urol 129: 1066–1074, 1983.
Pak CYC, Fuller C, Sakhaee K, Zerwekh JE, Adams BV: Management of cystine nephrolithiasis with alphamercaptopropionyl-glycine. J Urol 136: 1003–1008, 1986.
Harbar JA, Cusworth DC, Lawes LC, Wrong OM: Comparison of 2-mercaptopropionyl-glycine and D-penicillamine in the treatment of cystinuria. J Urol 136: 146–149, 1986.
Rodman JS, Blackburn P, Williams JJ, Brown A, Poapiaxhil MA, Peterson CM: The effect of dietAry protein on cystine excretion in patients with cystinuria. Clin Nephrol 22: 273278, 1984.
Personal communication, Mission Pharmacal Company.
Skovby F, Rosenberg LE, Thiers SO: No effect of L-glutamine on cystinuria. N Engl J Med 302: 236–237, 1980.
Jaeger P, Portmann L, Saunders A, Rosenberg LE, Thier SO: Anticystinuric effects of glutamine and of dietary sodium restriction. N Engl J Med 315: 1120–1123, 1986.
Al-Hariri SO, EL-Zouki AY: Captopril: a new treatment for cystinuria in children. Pediatr Nephrol 3: C196, 1989.
Martin X, Salas M, Labeeuw M, Pozet N, Gelet A, Dubernard JM: Cystine stones: the impact of new treatment. Br J Urol 68: 234 239, 1991.
Coulthard M, Richardson J, Fleetwood A: Captopril is not clinically useful in reducing the cystine load in cystinuria or cystinosis. Pediatr Nephrol 5: 98, 1991.
Bass RB, Beard JH, Cooner WH, Mosley BR, Pond HS, Rutherford CL Jr: Percutaneous ultrasonic lithotripsy in the community hospital. J Urol 133: 1586–1587, 1985.
Brannen GE, Bush WE: Percutaneous ultrasonic versus surgical removal of kidney stones. Surg Gynecol Obstet 161: 473478, 1985.
Grantham JR, Millner MR, Kande JV, Findlayson B, Hunter PT, Newman RC: Renal stone disease treated with extracorporeal shock wave lithotripsy: short term observations in 100 patients. Radiology 158: 203–206, 1986.
Wen SF: Glycosurias. In: HC Gorick, VM Buckalew Jr, eds, Renal Tubular Disorders. Pathophysiology, Diagnosis and Management. Marcel Dekker, New York, pp 131–157, 1985.
McSherry E: Renal tubular acidosis in childhood. Kidney Int 20: 799–809, 1981.
Batlle DC, Kurtzman NA: The defect in distal (Type I) renal tubular acidosis. In: HC Gorick, VM Buckalew Jr, eds, Renal Tubular Disorders. Pathophysiology, Diagnosis and Management. Marcel Dekker, New York, pp 281–305, 1985.
Buckalew VM Jr, Carvana RJ: The pathophysiology of distal (Type I) renal tubular acidosis. In: HC Gorick, VM Buckalew Jr, eds, Renal Tubular Disorders. Pathophysiology, Diagnosis and Management. Marcel Dekker, New York, pp 357–386, 1985.
McSherry E; Acidosis and growth in nonuremic renal disease. Kidney Int 14: 349–354, 1978.
Brenner RJ, Spring DB, Sebastian A, McSherry EM, Genant HK, Palubinskas AJ, Morris RC Jr: Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis. N Engl J Med 307: 217–222, 1982.
Buckalew VM Jr, Purvis ML, Shulman MG, Herndon CN, Rudman D: Hereditary renal tubular acidosis. Report of 64 member kindred with variable clinical expression including idiopathic hypercalciuria. Medicine (Baltimore) 53: 229–254, 1954.
Edelmann CM Jr: Isolated proximal (Type II) renal tubular acidosis. In: HC Gorick, VM Buckalew Jr, eds, Renal Tubular Disorders. Pathophysiology, Diagnosis and Management. Marcel Dekker, New York, pp 261–280, 1985.
Donckerwolcke RA, Van Stekelenburg GJ, Tiddens HA: Therapy of bicarbonate-losing renal tubular acidosis. Arch Dis Child 45: 774–779, 1970.
Boyer M, Proesmans W, Royer P: La titration des bicarbonates chez l’enfant normal et au cours de diveres nephropathies. Rev Etudes Clin Biol 14: 556–568, 1969.
Sebastian A, Schambelain M, Hulter HN, Maher T, Kurtz I, Biglieri EG, Rector FC Jr, Morris RC Jr: Hyperkalemic renal tubular acidosis. In: HC Gorick, VM Buckalew Jr, eds, Renal Tubular Disorders. Pathophysiology, Diagnosis and Management. Marcel Dekker, New York, pp 307–356, 1985.
Batlle DC, Arruda JAL, Kurtzman NA: Hyperkalemic renal tubular acidosis associated with obstructive uropathy. N Engl J Med 304: 373–380, 1981.
Portale AA, Booth BE, Morris RC Jr: Renal tubular acidosis. In: MA Holliday, TM Barratt, RL Vernier, eds, Pediatric Nephrology, 2nd ed. Williams and Wilkins, Baltimore, p 618, 1987.
Cheek DB, Perry JW: A salt wasting syndrome in infancy. Arch Dis Child 33: 252–256, 1958.
Chesney RW: Renal tubular disorders. In: HC Gonick, ed, Contemporary Nephrology, vol. 11. Yearbook Medical Publishers, Chicago, pp 107–138, 1988.
Armanini D, Kuhnle U, Strasser T, Dorr H, Butenandt T, Weber PC, Stockigt JR, Pearce P, Funder JW: Aldosteronereceptor deficiency in pseudohypoaldosteronism. N Engl J Med 313: 1178–1181, 1985.
Oberfield SE, Levine LS, Carey RM, Bejark B, New MI: Pseudohypoaldosteronism: multiple target organ unresponsiveness to mineralocorticoid hormones. J Clin Endocrinol Metab 48: 228–234, 1979.
DeFronzo RA: Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int 29: 186–202, 1980.
Schambelain M, Sebastian A, Biglieri EG: Prevalence, pathogenesis and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency. Kidney Int 17: 89–94, 1980.
Massry SG, Fredley RM, Coburn JW: Excretion of calcium and phosphate: physiology of their renal handling and relation to clinical medicine. Arch Intern Med 131: 828–859, 1973.
Chesney RW: Phosphaturic syndromes. In: HC Gorick, VM Buckalew Jr, eds, Renal Tubular Disorders. Pathophysiology, Diagnosis and Management. Marcel Dekker, New York, pp 201–238, 1985.
Tenenhouse HS: Effect of age and the X-linked hyp/y muta tion on renal adaptation to vitamin D and calcium deficiency. Can Biochem Physiol 81A: 367–371, 1985.
Tenenhouse HS: Abnormal renal mitochondrial 25- hydroxyvitamin D-lalpha-hydroxylase activity in the vitamin D and calcium deficient X-linked hyp/y mouse. Endocrinol ogy 113: 816–818, 1983.
Chesney RW, Mazess RB, Rose P, Hamstra AJ, DeLuca HF, Breed AL: Long-term inluence of calcitriol (1,25 dihy droxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets. Pediatrics 71: 559–567, 1983.
Latta K, Hisano S, Chan JCM: Therapeutics of X-linked hypophosphatemic rickets. Pediatr Nephrol 7: 744–748, 1993.
Marie PJ, Glorieux FM: Histomorphometric study of bone remodeling in hypophosphatemic vitamin D-resistant rickets. Metab Bone Dis Rel Res 3: 31–39, 1981.
Glorieux FM, Scriver CR, Reade TM, Goldman H, Roseborough A: Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemic rickets. N Engl J Med 287: 481–485, 1972.
Polisson RB, Martinez SJ, Khoury M, Harrell RM, Lyles KW, Friedman N, Harrelson JM, Reisner E, Drezner MK: Calcification of enthesis associated with X-linked hypophosphatemic osteomalacia. N Engl J Med 313: 1–6, 1985.
Wilson DM, Lee PDK, Morris AH, Reiter EO, Gertner JM, Marcus R, Quarmby VE, Rosenfeld RG: Growth hormone therapy in hypophosphatemic rickets. Am J Dis Child 145: 1165–1170, 1991.
Scriver CR: On phosphate transport and genetic screening, “understanding backward—living forward” in human genetics: William Allen Memorial Award Address. Am J HumGenet 31: 243–248, 1979.
Bijvoet OLM, Walton RJ: Nomogram for derivation of renal threshold phosphate concentration. Lancet 2: 309, 1979.
Terder M, Modai D, Samuel R, Arie R, Malabe A, Bab 1, Gabizon D, Lieberman VA: Hereditary hypophosphatemic rickets with hypercalciuria. N Engl J Med 312: 611–616, 1985.
Harrison HE, Harrison HC: Rickets and osteomalacia. In: Major Problems in Clinical Pediatrics: Disorders of Calcium and Phosphate Metabolism in Childhood and Adolescence, vol. 20. WB Saunders, Philadelphia, pp 141–256, 1979.
Drezner MK, Feinglos MN: Osteomalacia due to 1,25 dihydroxycholecalciferol deficiency. J Clin Invest 60: 1046 1053, 1977.
Dent CE, Stamp TCB: Hypophosphatemic osteomalacia presenting in adults. Q J Med 40: 303–329, 1971.
Lundberg E, Bergengren H, Lundquist B: Mild phosphate diabetes in adults. Acta Med Scand 204: 93–96, 1978.
Dent CE, Friedman M: Hypophosphatemic osteomalacia with complete recovery. Br Med J 1: 1676–1679, 1964.
Gitelman HJ, Graham JB, Welt LG: A new familial disorder characterised by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 79: 221, 1966.
Booth BE, Johanson A: Hypomagnesemia due to renal tubular defect in reabsorption of magnesium. J Pediatr 84:350 354, 1974. Inherited Renal Tubular Disorders 683
Evans RA, Carter JN, George CRP, et al.: The congenital magnesium-losing kidney. Q J Med 197: 39–52, 1981.
Agus ZS, Wasserstein A, Goldfarb S: Disorders of calcium and magnesium homeostasis. Am J Med 72: 473–488, 1982.
Carpenter TO, Key LL Jr: Disorders of the metabolism of calcium, phosphorus, and other divalent ions. In: I Ichikawa, ed, Pediatric Textbook of Fluids and Electrolytes. Williams and Wilkins, Baltimore, pp 237–268, 1990.
Rude RK, Oldham SB, Singer FR: Functional hypopara thyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin Endocrinol 5: 209–214, 1976.
Duran MJ, Borst GC, Osburne RC, Eil C: Concurrent renal hypomagnesemia and hypoparathyroidism with normal parathormone responsiveness. Am J Med 76: 151–154, 1984.
Ralston S, Boyle IT, Cowan RA, Creau GP, Jenkins A, Thomson WS: PTH and vitamin D responses during treatment of hypomagnesemic hypoparathyroidism. Acta Endocrinol 103: 535–538, 1983.
Rude RK, Adams JS, Ryzen E, Endres DB, Niimi H, Horst RL, Haddad JG, Singer FR: Low serum concentrations of 1,25 dihydroxyvitamin D in human magnesium deficiency. J Clin Endocrinol Metab 61: 933–940, 1985.
Zelikovic I, Dabbagh S, Friedman AL, Goelzer ML, Chesney RW: Severe renal osteodystrophy without elevated serum immunoreactive parathyroid hormone concentrations in hypomagnesemia due to renal magnesium wasting. Pediatrics 79: 403–409, 1987.
Allen DB, Friedman AL, Greer FR, Chesney RW: Hypomagnesemia masking the appearance of elevated parathyroid hormone concentrations in familial pseudo hypoparathyroidism. Am J Med Genet 31: 153–158, 1988.
Brewer ED: The Fanconi syndrome: clinical disorders. In: HC Gorick, VM Buckalew Jr, eds, Renal Tubular Disorders.Pathophysiology, Diagnosis and Management. Marcel Dekker, New York, pp 475–544, 1985.
Chesney RW: Etiology and pathogenesis of the Fanconi syn drome. Miner Electrolyte Metab 4: 303–316, 1980.
Wallis LA, Engle RL: The adult Fanconi syndrome II: Review of eighteen cases. Ann J Med 22: 13–23, 1957.
Gahl WA: Cystinosis coming of age. Adv Pediatr 33: 95–126, 1986.
Schneider JA: Therapy of cystinosis. N Engl J Med 313: 1473–1474, 1985.
Gahl WA, Thoene JG, Schneider JA, Mendoza SA, Schulman JG: Results of the national collaborative cysteamine study: improvement in linear growth and slowed progression of renal failure. N Engl J Med 366: 971–977, 1987.
Gahl WA, Schneider JA, Thoene JG, Chesney RW: Course of nephropathic cystinosis after 10 years of age. J Pediatr 109: 605–608, 1986.
Bennardini I, Rizzo WB, Dalakas M, Berner J, Gahl WA: Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J Clin Invest 75: 1124–1130, 1985.
Abassi V, Lowe CU, Calcagno PL: Oculo-cerebro-renal syndrome. A review. Am J Dis Child 115: 145–168, 1968.
Segal S: Disorders of galactose metabolism. In: JB Stanbury, JB Wyngaarden, DS Frederickson, JL Goldstein, MS Brown, eds, The Metabolic Basis of Inherited Disease, 5th ed. McGraw-Hill, New York, pp 166–191, 1983.
Lindbald B, Lindstedt S, Steen G: On the enzymic defects in hereditary tyrosinemia. Proc Natl Acad Sci USA 74: 46414645, 1977.
Scriver CR, Silverberg M, Clow CL: Hereditary tyrosinemia and tyrosyluria: clinical report of four patients. Can Med Assoc J 97: 1047–1050, 1967.
Steinmann B, Gitzelmann R: The diagnosis of hereditary fructose intolerance. Hell, Paediatr Acta 36: 297–316, 1981.
Chesney RW, Kaplan BS, Teitel D, Colle E, McInnes RR, Goldman M, Scriver CR: Metabolic abnormalities in the idiopathic Fanconi syndrome: studies of carbohydrate metabolism in two patients. Pediatrics 67: 113–118, 1981.
Brodehl J, Gelessen K, Hagge W: The Fanconi syndrome in hepatorenal glycogen storage disease in progress. In: G Peiters, F Roch-Rainel, eds, Nephrology. Springer-Verlag, New York, pp 241–243, 1969.
Strickland GT, Lew ML: Wilson’s disease, clinical and laboratory manifestations in 40 patients. Medicine (Baltimore) 54: 113–137, 1975.
Beam AG, Yu TF, Gutman AB: Renal function in Wilson’s disease. J Clin Invest 36: 1107–1114, 1957.
Walshe JM: Effect of penicillamine on failure of renal acidification in Wilson’s disease. Lancet 1: 775–779, 1985.
Walshe JM: Treatment of Wilson’s disease with tirentine (trithlene tetramine) dihydrochloride. Lancet 1: 643–647, 1982.
Maldonado JE, Velosa JA, Kyle RA, Wagoner RA, Molley KE, Salassa RM: Fanconi syndrome in adults. A manifestation of a latent form of myeloma. Am J Med 58: 354–364, 1975.
Burke EC, Holley KE, Stickler GB: Familial nephrotic syndrome with nephrocalcinosis and tubular dysfunction. J Pediatr 82: 202–206, 1973.
Bergstein JM, Litman N: Interstitial nephritis with anti-tubular basement membrane antibody. N Engl J Med 292: 875–878, 1975.
Friedman AL, Chesney RW: Fanconi’s syndrome in renal transplantation. Am J Nephrol 1: 45–47, 1981.
Mavromatis F: Tetracycline nephropathy. JAMA 193: 10: 191194, 1965.
Otter J, Vis HL: Acute reversible renal tubular dysfunction following intoxication with methyl-3-chromone. J Pediatr 73: 422–425, 1968.
Chrisolm JJ: Increased lead absorption and lead poisoning. In: RE Behrman, VC Vaughn, eds, Nelson Textbook of Pediatrics, 11th ed. WB Saunders, Philadelphia, pp 1801–1804, 1983.
Hoakawa Y, Abe J, Tamaka S: Bone changes in experimental chronic cadmium poisoning. Arch Environ Health 26: 24 1244, 1973.
Chesney RW, Harrison HE: Fanconi syndrome following bowel surgery and hepatitis reversed by 25hydroxycholecalciferol. J Pediatr 86: 857–861, 1975.
Gill JR Jr: Bartter’s syndrome. In: HC Gorick, VM Buckalew Jr, eds, Renal Tubular Disorders. Pathophysiology, Diagnosis and Management. Marcel Dekker, New York, pp 457–473, 1985.
Tomko DJ, Yeh BPY, Falls WF Jr: Bartter’s syndrome. Study of a 52 year old man with evidence for a defect in proximal tubular sodium reabsorption and comments on therapy. Am J Med 61: 111–117, 1976.
Pererra RR, Von Wersch J: Inheritance of Bartter syndrome. Am J Med Genet 15: 79–84, 1983.
White MG: Bartter’s syndrome. A manifestation of renal tubular defects. Arch Intern Med 129: 41–47, 1972.
Gill JR, Frohlich JC, Bowden RE, Taylor AA, Keiser HR, Seyberth HV, Oates JA, Bartter FC: Bartter’s syndrome: a disorder characterized by high urinary prostaglandins and dependence of hypereninemia on prostaglandin synthesis. Am J Med 61: 43–51, 1976.
Halushka PV, Wohltmann H, Privitera PJ, Hurwitz G, Margolius HS: Bartter’s syndrome: urinary prostaglandin E-like material and kallikrein: indomethacin effects. Ann Intern Med 87: 281–286, 1977.
Veldhius JD, Bardin CW, Demers LM: Metabolic mimicry of Bartter’s syndrome to covert vomiting. Am J Med 66: 36 1363, 1979.
Stein JH: The pathogenic spectrum of Bartter’s syndrome. Kidney Int 28: 85–93, 1985.
Seyberth HW, Rascher W, Schweer H, Kuhl PG, Mehls O, Scharer K: Congenital hypokalemia with hypercalcemia in preterm infants. A hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr 107: 694–698, 1985.
Hornuch I, Huet de Barochez Y, Bariety J, Branca GF, Vigeral P, Girard JF, Kazatchkine M, DeGennes JL, Truffert J, Bocquet L, Paris M: Bartter’s syndrome with normal sodium chloride reabsorption during indomethacin treatment. Nephron 46: 137–143, 1987.
Gullner HC, Bartter FC, Gill JR Jr, Bickman PS, Wilson CB, Tiwari JL: A sibship with hypokalemic alkalosis and renal proximal tubulopathy. Arch Intern Med 143: 1534–1537, 1983.
Fishman MP, Teifer N, Zia P, Speckart P, Golub M, Rude R: Role of prostaglandins in the pathogenesis of Bartter’s syndrome. Am J Med 60: 785–797, 1976.
Griffing GT, Melby JC: The therapeutic use of a new potassium-sparing diuretic, amiloride, and converting enzyme inhibitor, MK 421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism. Clin Exp Hypertens A5: 779–801, 1983.
Liddle GW, Bledsow T, Coppage WS Jr: A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Physicians 76: 199, 1963.
Wang C, Chan TK, Yeung RTT, et al.: The effect of triamterene and sodium intake on renin aldosterone and erythrocyte sodium transport in Liddle’s syndrome. J Clin Endocrinol Metab 52: 1027, 1981.
Botero-Velez M, Curtis JJ, Warnock DG: Brief report: Liddle’s syndrome revisited-a disorder of sidum reabsorption in the distal tubule. N Engl J Med 330: 178–181, 1994.
Rodriguez-Soriano J, Valle A, Dominguez MJ: “Chloride-shunt” syndrome: an overlooked cause of renal hypercalciuria. Pediatr Nephrol 3: 113–121, 1989.
Gordon RD, Geddes RA, Dawsey CGK, O’Halloran MW: Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Australas Ann Med 4: 287–294, 1970.
Gordon RD: Syndrome of hypertension and hyperkalaemia with normal glomerular filtration rate. Hypertension 8: 93102, 1986.
Spitzer A, Edelmann CM Jr, Goldberg LD, Henneman PH: Short stature, hyperkalemia and acidosis: a defect in renal transport of potassium. Kidney hit 3: 251–257, 1973.
Weinstein SF, Allen DME, Mendoza SA: Hyperkalemia, acidosis and short stature associated with a defect in renal potassium excretion. J Pediatr 85: 355–358, 1974.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Batisky, D.L., Chesney, R.W. (1998). Inherited Renal Tubular Disorders. In: Suki, W.N., Massry, S.G. (eds) Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6632-5_40
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6632-5_40
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6634-9
Online ISBN: 978-1-4757-6632-5
eBook Packages: Springer Book Archive